Efficacy and Safety of Tenapanor on Hyperphosphatemia in Japanese Hemodialysis Patients: Results of a Randomized Phase 3 Trial

被引：0
|
作者：
Fukagawa, Masafumi [1 ]
Ikejiri, Kazuaki [2 ]
Kinoshita, Jun [2 ]
Nakanishi, Kaoru [2 ]
Akizawa, Tadao [3 ]
机构：
[1] Tokai Univ, Sch Med, Isehara, Kanagawa, Japan
[2] Kyowa Kirin Co Ltd, Tokyo, Japan
[3] Showa Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO160
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis
    Yu, Shanshen
    Sun, Jia
    Guo, Xiafei
    RENAL FAILURE, 2024, 46 (02)
  • [42] Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial
    Dwyer, Jamie P.
    Sika, Mohammed
    Schulman, Gerald
    Chang, Ingrid J.
    Anger, Michael
    Smith, Mark
    Kaplan, Mark
    Zeig, Steven
    Koury, Mark J.
    Blumenthal, Samuel S.
    Lewis, Julia B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (05) : 759 - 766
  • [43] Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
    Block, Geoffrey A.
    Bleyer, Anthony J.
    Silva, Arnold L.
    Weiner, Daniel E.
    Lynn, Robert, I
    Yang, Yang
    Rosenbaum, David P.
    Chertow, Glenn M.
    KIDNEY360, 2021, 2 (10): : 1600 - 1610
  • [44] Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12-week, Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
    Chey, William D.
    Lembo, Anthony J.
    Korner, Paul
    Yan, Andrew
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S226 - S227
  • [45] Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial
    Morand, Eric
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian
    Askanase, Anca
    Riche'z, Christophe
    Bae, Sang-Cheol
    Brohawn, Philip
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] EFFICACY AND SAFETY OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF THE SECOND PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Morand, Eric F.
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian N.
    Askanase, Anca D.
    Richez, Christophe
    Bae, Sang-Cheol
    Brohawn, Mr Philip Z.
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 22 - 23
  • [47] Efficacy and safety of tenapanor vs placebo in treating CKD patients on dialysis and with hyperphosphatemia: a systematic review and meta-analysis of 2251 patients
    Abo Elnaga, Ahmed A.
    Serag, Ibrahim
    Alsaied, Mohamed A.
    Khalefa, Basma Badrawy
    Rajput, Jaisingh
    Ramadan, Shrouk
    Elettreby, Abdelrahman M.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024,
  • [48] Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Kuwana, Masataka
    Allanore, Yannick
    Batalov, Anastas
    Butrimiene, Irena
    Carreira, Patricia
    Cerinic, Marco Matucci
    Distler, Oliver
    Kaliterna, Dusanka Martinovic
    Mihai, Carina
    Mogensen, Mette
    Olesinska, Marzena
    Pope, Janet E.
    Riemekasten, Gabriela
    Rodriguez-Reyna, Tatiana S.
    Jose Santos, Maria
    van Laar, Jacob
    Spotswood, Helen
    Siegel, Jeffrey
    Jahreis, Angelika
    Furst, Daniel E.
    Denton, Christopher P.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
    Hisashi Hidaka
    Namiki Izumi
    Takeshi Aramaki
    Masafumi Ikeda
    Yoshitaka Inaba
    Kazuho Imanaka
    Takuji Okusaka
    Susumu Kanazawa
    Shuichi Kaneko
    Shinichi Kora
    Hiroya Saito
    Junji Furuse
    Osamu Matsui
    Tatsuya Yamashita
    Osamu Yokosuka
    Satoshi Morita
    Hitoshi Arioka
    Masatoshi Kudo
    Yasuaki Arai
    Medical Oncology, 2019, 36
  • [50] Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
    Hidaka, Hisashi
    Izumi, Namiki
    Aramaki, Takeshi
    Ikeda, Masafumi
    Inaba, Yoshitaka
    Imanaka, Kazuho
    Okusaka, Takuji
    Kanazawa, Susumu
    Kaneko, Shuichi
    Kora, Shinichi
    Saito, Hiroya
    Furuse, Junji
    Matsui, Osamu
    Yamashita, Tatsuya
    Yokosuka, Osamu
    Morita, Satoshi
    Arioka, Hitoshi
    Kudo, Masatoshi
    Arai, Yasuaki
    MEDICAL ONCOLOGY, 2019, 36 (06)
12345